#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>By report
Available Antigens Included: *Not all markers will be reported in all cases. Requests for specific markers to be included must be listed on manual requisition or by footnote for electronic orders. We do not offer individual markers without also running our panel.
T-cell: CD1, CD2, CD3, CD4, CD5, CD7, CD8, TCR alpha-beta, TCR gamma-delta, Cytoplasmic CD3 B-cell: CD10, CD19, CD20, CD22, CD23, CD24, CD79b, CD103, Kappa, Lambda, FMC7, Cytoplasmic Kappa, Cytoplasmic Lambda Myelo/Mono: CD11b, CD13, CD14 (Mo2), CD14 (MY4), CD15, CD33, CD64, CD117, myeloperoxidase Misc: CD11c, CD16, CD25, CD30, CD34, CD38, CD41, CD42b, CD45, CD56, CD57, CD61, HLA-DR, glycophorin, TdT, bcl-2
*ExistRefRange>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>
Please refer to Statement A in the Compliance Statements section in the front of the Laboratory Test Directory.
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistNote>
| Note: |
Surface markers in leukemia and lymphoma may aid in identifying the tumor lineage for diagnostic and prognostic purposes. After review of the clinical history and morphology, a panel of markers is selected for each case by a board-certified pathologist. In most cases, the lineage can be identified as T-cell, B-cell, or myeloid and a diagnosis, or differential diagnosis, can be made.
|
*ExistNote>
#ExistCPT>
| CPT Code(s): |
88184 First marker and 88185 Each additional marker; AND 88187 Interpretation for 2-8 markers or 88188 Interpretation for 9-15 markers or 88189 Interpretation for 16 or more markers.
|
*ExistCPT>
|